PDK1 inhibition was also shown to be effective in AML cells lines, linked to a reduction in BCL2 and BCL-XL expression, increased PARP and Caspase-mediated apoptosis and a loss of autophagy regulators42. This evidence concerns the gene BCL2 and acute myeloid leukemia.